Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announce an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance through a strategic €6.0 million (AU$9.6 million) investment to develop new hybrid pharmaceutical-device products...
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM
MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Vienna from 9 – 13 September 2023. Further data from Telix's completed pivotal...
WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards
SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract, Research, Development, and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, announced it has been named the winner of the "Best Contract Development Manufacturing Organization (CDMO)" prize at the 2023 World ADC Awards. The award is a reflection of the company's continual enhancement of its...
BRIAN COX WARNS THE WORLD ABOUT WORKPLACE MENTAL HEALTH THREAT IN PSA FOR ASICS
Global study shows that our mental state starts to decline after only two hours of continuous desk-based working, but just 15 minutes of exercise can help to reverse the effects ASICS enlists Brian Cox to take on the role of the world's scariest boss to highlight the real threat to our mental health – the desk we work...
Nippon Express Obtains GDP Certification for Temperature-controlled Facility at Kansai International Airport
TOKYO, Feb. 22, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification, effective January 11, for NX-PHARMA Logistics Hub Kansai Airport, a temperature-controlled facility being operated inside the international cargo area of Kansai International Airport, evidencing its compliance with GDP standards for...
The IND application of Biosyngen BRG01 Therapy was accepted by CDE
GUANGZHOU, China, Sept. 28, 2022 /PRNewswire/ -- The IND application of Biosyngen BRG01 Therapy has been accepted for review by the Center for Drug Evaluation, China (CXSL2200487)（https://www.cde.org.cn/main/xxgk/listpage/9f9c74c73e0f8f56a8bfbc646055026d）. BRG01 Therapy is autologous T cell therapy for relapsed/metastatic nasopharyngeal cancer (NPC) treatment. The principle of the autologous T cell therapy is to genetically modify patients'...
Farrer Park Hospital launches clinical collaboration with ARC Hospitals
SINGAPORE, Feb. 17, 2023 /PRNewswire/ -- Farrer Park Hospital (FPH) has launched a clinical collaboration with Allegiant Regional Care (ARC) Hospitals to promote continuing medical education among specialists and physicians. The collaboration was officially launched at a joint surgical conference held at Cebu, Philippines on 11 February. The conference marked the start of the two healthcare providers' plans to...
PCA 500™– the world’s most efficient and versatile 12-lead ECG, receives FDA clearance for use in acute care
LOS ANGELES, Feb. 14, 2024 /PRNewswire/ -- QT Medical, a medtech company focusing on improving cardiac care with electrocardiogram (ECG or EKG), announces that it has received 510(k) clearance from the FDA for PCA 500™ use in acute care. PCA 500 was first 510(k) cleared in 2018 for professional and personal use by adults in non-acute care settings, including...
Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities
New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced the availability of Immediate Spin Crossmatch (ISXM) on the company's ORTHO...
Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery
Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTRUM™ SYDNEY, Feb. 16, 2023 /PRNewswire/ -- February 16, 2023, Inventia Life Science, a world leader in advanced cell models for biomedical research and drug discovery, today announced a collaboration with MSD (tradename of Merck &...
